Bloomage Biotechnology Corporation Limited
Research Bloomage Biotechnology Corporation Limited (688363.SS) on Bullrun: market cap CNY 16.54B, P/E 71.5, dividend yield 0.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker688363.SS
- ExchangeSS
- CountryChina
- SectorBasic Materials
- IndustrySpecialty Chemicals
- CurrencyCNY
- Market capCNY 16.54B
- P/E71.5
- Dividend yield0.6%
- Financial periodQ2 2026
- RevenueCNY 926.77M
- Net incomeCNY 88.13M
- Free cash flowCNY 321.25M
- Gross margin68.0%
Valuation Snapshot
latest market cap is CNY 16.54B; P/E is 71.5; dividend yield is 0.6%.
Peer valuation comparison
Latest P/E is 71.54x versus a Basic Materials sector median of 14.77x (384.2% above).
Latest dividend yield is 0.55% versus a Basic Materials sector median of 2.67% (79.4% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-11-11 | CNY 16.54B | 71.5 | 0.6% | 0.19 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.19 CNY, yield 0.6%.
About Bloomage Biotechnology Corporation Limited
Bloomage BioTechnology Corporation Limited develops, produces, and sells bioactive materials. It offers beauty and care products under the Hymagic-VCHA VC Hylauronic Acid; Biomeet-MarineDNA; Bioyouth-SPG Schizophyllan Gel; Hymagic-GluHA; Bloomsurfact EncapCare RP; Bloomsurfact Sodium Surfactin; Hybloom Minitrue; Bioyouth-EGT Pure Ultrapure Ergothioneine; miniHA HA-Oligo degraded by hyaluronidase; microHA Super Active Hyaluronic Acid; Hymagic-AcHA Sodium Acetylated Hyaluronate; Hymagic-4D 4D Hyaluronic Acid;
ETFs that hold Bloomage Biotechnology Corporation Limited
US-listed ETFs
Bloomage Biotechnology Corporation Limited is held by 16 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | <0.01% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| Vanguard FTSE All-World ex-US Index Fund ETF Shares (VEU) | <0.01% | 0.04% |
| Schwab Emerging Markets Equity ETF (SCHE) | <0.01% | 0.06% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| Dimensional World ex U.S. Core Equity 2 ETF (DFAX) | <0.01% | 0.28% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Basic Materials stocks
Frequently asked questions
What is Bloomage Biotechnology Corporation Limited's market cap?
Bloomage Biotechnology Corporation Limited's market capitalization is CNY 16.54B.
What is Bloomage Biotechnology Corporation Limited's P/E ratio?
Bloomage Biotechnology Corporation Limited's price-to-earnings (P/E) ratio is 71.5.
Does Bloomage Biotechnology Corporation Limited pay a dividend?
Bloomage Biotechnology Corporation Limited has a dividend yield of 0.6%.
What does Bloomage Biotechnology Corporation Limited do?
Bloomage BioTechnology Corporation Limited develops, produces, and sells bioactive materials. It offers beauty and care products under the Hymagic-VCHA VC Hylauronic Acid; Biomeet-MarineDNA; Bioyouth-SPG Schizophyllan Gel; Hymagic-GluHA; Bloomsurfact EncapCare RP; Bloomsurfact Sodium Surfactin; Hybloom Minitrue; Bioyouth-EGT Pure Ultrapure Ergothioneine; miniHA HA-Oligo degraded by hyaluronidase; microHA Super Active Hyaluronic Acid; Hymagic-AcHA Sodium Acetylated Hyaluronate; Hymagic-4D 4D Hyaluronic Acid; Hybloom Zinc Hyaluronate; Hybloom Sodium Hyaluronate 1% Solution; Hybloom Sodium.